SNP Communication Genetic Variations of the ABC Transporter Gene ABCC3 in a Japanese Population
Total Page:16
File Type:pdf, Size:1020Kb
Drug Metab. Pharmacokinet. 22 (2): SNP22 (129)SNP28 (135) (2007). SNP Communication Genetic Variations of the ABC Transporter Gene ABCC3 in a Japanese Population Hiromi FUKUSHIMAUESAKA1, Yoshiro SAITO1,2,*,KeikoMAEKAWA1,2, Ryuichi HASEGAWA3, Kazuko SUZUKI4,TatsuoYANAGAWA4, Hiroshi KAJIO5, Nobuaki KUZUYA5, Mitsuhiko NODA5, Kazuki YASUDA6, Masahiro TOHKIN1,3 and Junichi SAWADA1,2 1Project Team for Pharmacogenetics, 2Division of Biochemistry and Immunochemistry, 3Division of Medicinal Safety Science, National Institute of Health Sciences, Tokyo, Japan 4Nerima General Hospital, Tokyo, Japan, 5Division of Endocrine and Metabolic Diseases, the Hospital, 6Department of Metabolic Disorder, Research Institute, International Medical Center of Japan, Tokyo, Japan Full text of this paper is available at http://www.jstage.jst.go.jp/browse/dmpk Summary: An ATPbinding cassette transporter, multidrug resistancerelated protein 3 (MRP3), is encoded by the ABCC3 gene. The MRP3 protein is expressed in several tissues, and functions as an eux transporter for conjugated as well as unconjugated substrates. In this study, the 31 ABCC3 exons and their anking introns were comprehensively screened for genetic variations in 89 Japanese subjects. Fortysix genetic variations, including 21 novel ones, were found: 8 were located in the 5?anking region, 14 in the coding exons (8 synonymous and 6 nonsynonymous variations), and 24 in the introns. Of these 46 variations, ve novel nonsynonymous variations, 2221CÀT (Gln741Stop), 2395GÀA (Val799Met), 2798ä2799delAG (Gln933ArgfsX64), 3657CÀA (Ser1219Arg), and 4217CÀT (Thr1406Met), were found as heterozygous variations. The allele frequencies were 0.011 for Ser1219Arg and 0.006 for the other four variations. Gln741Stop induces a stop codon at codon 741. Gln933ArgfsX64 causes a frameshift at codon 933, resulting in early termination at codon 997. Both variations result in loss of 6 transmembrane helices (from the 12th to 17th helices) in the Cterminus and all regions of nucleotide binding domain 2. Thus, both variant proteins are assumed to be inactive. These data provide fundamental and useful information for pharmacogenetic studies on MRP3transported drugs in Japanese. Key words: ABCC3; direct sequencing; novel genetic variation; amino acid change encoded by the ATPbinding cassette transporter C3 Introduction gene (ABCC3 ), and the most homologous to MRP1 The multidrug resistancerelated protein 3 (MRP3) is among MRP family members.1) The ABCC3 gene consists of 31 exons spanning approximately 57 kb at chromosome 17q22, encodes 1527 amino acids, and the As of October 22, 2006, the novel variations reported here are not found in the database of Japanese Single Nucleotide Polymorphisms resulting membrane proteins (190 and 170 kDa) have 15) (http:WWsnp.ims.utokyo.ac.jpW), dbSNP in the National Center for dierent glycosylation patterns. MRP3 mRNA and Biotechnology Information (http:WWwww.ncbi.nlm.nih.govWSNPW), protein are expressed in several tissues including adrenal or PharmGKB Database (http:WWwww.pharmgkb.orgW). gland, liver, small intestine, colon, kidney, and pan This study was supported in part by the Program for the Promotion of creas.17) MRP3 protein is localized to the basolateral Fundamental Studies in Health Sciences and the Health and Labor Sciences Research Grants (Research on Advanced Medical Technolo membranes of the cells in epithelia and thought to play a gy) from the Ministry of Health, Labor and Welfare. role in the eux of organic anions including drugs.1,5,7) Received; October 23, 2006, Accepted; November 16, 2006 *To whom correspondence should be addressed: Yoshiro SAITO,Ph.D.,Division of Biochemistry and Immunochemistry, National Institute of Health Sciences, 1181 Kamiyoga, Setagayaku, Tokyo 1588501, Japan. Tel. {81357173831, Fax. {81357173832, Email: yoshiro nihs.go.jp SNP22 (129) SNP23 (130) Hiromi FUKUSHIMAUESAKA, et al. Similar to MRP1 protein, MRP3 is predicted to have 17 Materials and Methods transmembrane helices (TM) in three membrane span ning domains (consisting of TM1 to TM5, TM6 to Human genomic DNA samples: Eightynine TM11, and TM12 to TM17) and two large cytoplasmic Japanese diabetic subjects administered glimepiride domains between TM11 and TM12, and downstream of participated in this study with written informed consent. TM17.1,3) These two cytoplasmic domains contain Genomic DNA was extracted from blood leukocytes. nucleotide binding domains (NBD1 and NBD2), where The ethical review boards of the International Medical binding and hydrolysis of ATP occur to facilitate sub Center of Japan, Nerima General Hospital, and the strate transport. Three sequence motifs in each NBD are National Institute of HealthSciences approved this also conserved in the MRP3 protein, called Walker A, study. Walker B and ABC signature sequence.1,3) PCR conditions for DNA sequencing and linkage Human MRP3 can transport glucuronide, sulfate disequilibrium (LD)analysis: Genomic and mRNA and glutathioneconjugates such as the estradiol 17bD sequences of ABCC3 obtained from GenBank glucuronide, dinitrophenyl Sglutathione and leu (NTä010783.14 and NMä003786.2, respectively) were kotriene C4, and also some bile acids including used for primer design and as reference sequences. First, glycocholate.1,8,9) In vitro studies have also indicated multiplex longrange PCR was performed to amplify all that overexpression of MRP3 confers resistance to 31 exons of ABCC3 from 100 ng of genomic DNA using anticancer drugs etoposide and teniposide.8,10) In 0.025 unitsWmL of ZTaq (Takara Bio Inc., Shiga, contrast to MRP1 and MRP2, depletion of cellular Japan) withfour sets of primers (1 mM) designed in the glutathione did not inuence the resistance to etoposide intronic regions as listed in Table 1 (``1st PCR''). The and teniposide, and MRP3 could not eux glutathione rst PCR conditions were 30 cycles of 989C for 5 sec, itself.8,10) Thefolateanaloguesmethotrexateand559C for 5 sec, and 729C for 190 sec. Next, eachexon, leucovorin are also substrates of MRP3.11) In addition, a except for exon 1, was amplied separately in the 2nd recent report showed that an antidiabetic drug, glybu PCR using the 1st PCR product as a template by Ex ride, was transported by MRP3.12) In mice, knockout Taq (0.02 unitsWmL, Takara Bio Inc.) withprimers (0.2 of the ABCC3 gene altered pharmacokinetics of mM) listed in ``2nd PCR'' in Table 1.Becauseofahigh morphine3glucuronide, and decreased antinocicep GC content, exon 1 was amplied using 0.05 unitsWmL tive eects of interperitoneally injected morphine of LATaq (Takara Bio Inc.) in GC buer I with0.5 mM 6glucuronide.13) Thus, MRP3 is thought to be involved of the primers listed in Table 1. The second PCR in tissue distribution of anionic compounds, which conditions were 949C for 5 min, followed by 30 cycles includes drugs. of 949C for 30 sec, 609Cfor1min,and729Cfor2min, MRP3 mRNA and protein expression levels were and then a nal extension at 729Cfor7min.ThePCR reported to vary 86 and 84fold, respectively, in products were then treated with a PCR Product Pre Caucasian livers.14) Thesevariationsmaybecausedin Sequencing Kit (USB Co., Cleveland, OH, USA) and part by transcriptional regulation. Expression of MRP3 directly sequenced on bothstrands using an ABI BigDye mRNA was enhanced by pregnane X receptor agonists Terminator Cycle Sequencing Kit version 3.1 (Applied suchas rifampicin, 15) andalsobyomeprazoleand Biosystems, Foster City, CA, USA) and the sequencing bnaphtoavone, possibly through aryl hydrocarbon primers listed in Table 1 (Sequencing). Excess dye was receptor pathway.16) MRP3 expression is also induced removed by a DyeEx96 kit (Qiagen, Hilden, Germany) by bile salts such as chenodeoxycholic acid through andtheeluateswereappliedtoanABIPrism3730DNA induction of a1 fetoprotein transcription factor, which Analyzer (Applied Biosystems). All rare novel varia binds to the two elements located 224 to 195 bases tions were conrmed by repeated sequencing analyses of upstream of the translational start site.17) PCR products generated by new genomic DNA In addition, genetic polymorphisms are known in the amplications. Under the conditions used, up to 2.1 kb ABCC3 gene. Fiftyone polymorphisms, including 6 upstream of the translational start site, all exons and nonsynonymous ones, were reported in Caucasians.14) their anking introns were successfully sequenced for all One polymorphism, |211CÀT, had a signicant corre subjects. The nucleotide positions based on the cDNA lation withreduced mRNA expression levels in theliver. sequence were numbered from the adenine of the Saito et al. found 35 genetic polymorphisms, including 3 translational initiation site or the nearest exons. synonymous ones, in 48 Japanese subjects.18) However, HardyWeinberg equilibrium and linkage dise no nonsynonymous polymorphism was reported for quilibrium (LD) analyses were performed withSNPA Asian populations, which included the Japanese. lyze version 3.1 (Dynacom Co., Yokohama, Japan), In this study, we searched for genetic variations in and pairwise LDs between variations were obtained for ABCC3 by resequencing all 31 exons and their sur rho square (r 2)and`D?` values. rounding introns from 89 Japanese subjects. Genetic Variations of ABCC3 in Japanese SNP24 (131) Table 1. ABCC3 sequencing primers Amplied or ? ? ? ? Amplied sequenced region Forward primer (5 to 3 ) Reverse primer (5 to 3 ) length (bp) 1st PCR |2k to Exon 1 AGCCTTGGGAAAGCAATAGCGATAG TCTGTGAGAAGGGAGTTGGACTACA